PRELIMINARY VALIDATION STUDY OF PARAOXONASE-1 IN HORSES by Bonelli, F et al.
SUSPECTED MARSH MALLOW (MALVA PARVIFLORA)
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Four horses from the same farm were examined on sequential
days for acute onset of severe muscle fasciculations, tachycardia,
sweating and periods of recumbency. All were kept in a paddock
with minimal pasture coverage but extensive growth of Malva
parviflora, which they were grazing. Feed supplementation was
minimal. Horse 1 was euthanized on the farm due to rapid clinical
deterioration. Horse 2 was referred for hospital care where it was
determined to have severe myocardial disease and generalised
myopathy; this horse was euthanized due to prolonged recum-
bency and severe cardiac arrhythmias 36 h after admission. Horse
3 died during transport to hospital, and horse 4 was euthanized at
onset of clinical signs. Post mortem examinations performed on
horses 2, 3 and 4 revealed acute, multifocal, monophasic
myonecrosis of cardiac and skeletal muscle. Myocyte glycogen
accumulation was absent (PAS stain; horse 2). Acyl carnitine pro-
files were performed on serum from horses 2 and 4 and equine
controls. These revealed increased C14-C18 acyl carnitines in cases
relative to controls. Malvalic, sterculic, and dihydrosterculic acids
(present in Malva parviflora) were grossly increased in sera of cases
relative to controls. The prominent cardiac component and differ-
ent acyl carnitine profile suggests a different aetiology to atypical/
seasonal pasture myopathy. We hypothesise that these cyclo-
propene fatty acids found in Malva parviflora interfere with fatty
acid beta-oxidation in horses in negative energy balance, causing
the clinical signs and abnormal acyl carnitine profiles. These
equine cases closely resemble the human genetic condition Very
Long Chain Acyl CoA Dehydrogenase Deficiency.
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Paraoxonase-1 (PON-1) is an anti-oxidant enzyme associated
with high-density lipoproteins in blood. PON-1 is a negative
acute-phase protein being its plasmatic activity reduced during
inflammation due to consumption by oxidants. Considering the
possible clinical usefulness of PON-1 as an early inflammatory
marker this is a preliminary validation study in horses.
Serum PON-1 activity was measured in 69 clinically healthy ani-
mals (31 adult female, 18 geldings, 11 stallions, 9 foals) using an
enzymatic method adapted from other species. In order to prelimi-
narily assess the possible utility of PON-1 as a marker of Systemic
Inflammatory Response Syndrome (SIRS), blood from 6 sick
foals, classified according to a validated SIRS scale, was analyzed.
Intra- and inter-assay imprecision were assessed by repeated analy-
sis of pooled samples and evaluation of coefficient of variations
(CV). Accuracy was indirectly evaluated through linearity under
dilution (LUD) and spiking recovery test (SRT). Results of the
different groups of healthy horses were compared to each other
with a Friedmann test with Bonferroni correction. The method is
precise (inter- and inter-assay CVs <5%) and accurate (LUD and
SRT fit the linear model). PON-1 activity was higher in foals and
in adult females (mean  SD: 63.7  15.5 and 60.8  10.1,
respectively) than in geldings and adult males (52.5  10.2 and
47.2  7.7, respectively). In 3/6 SIRS foals PON-1 activity was
lower than the lowest percentile of distribution of healthy foals.
This study demonstrated that the method of measurement of
PON-1 activity in horses is precise and accurate and PON-1 may
be a marker of SIRS.
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Antimicrobial resistance is a growing concern and associated
with antimicrobial use. Data from several countries has shown
that inappropriate use of antimicrobials is common among equine
practitioners. The objective of this study was to investigate the
antimicrobial prescribing practices of equine practitioners in Aus-
tria, Germany and Switzerland.
An online questionnaire including six clinical scenarios was sent
to all members of the equine veterinary associations of Germany,
Switzerland and Austria. Antimicrobial choice and dosage were
compared to each country’s licensing bodies and current published
scientific guidelines. To establish association of demographic fac-
tors with use of critically important antimicrobials and underdos-
ing, logistic regression analysis was performed.
Antimicrobials were prescribed for diseases with an unlikely
bacterial origin by 36–84% of respondents, of which 8–12%
selected a critically important antimicrobial. Use of third or fourth
generation cephalosporins was associated with type of practice
(P = 0.03) and number of veterinarians employed (P = 0.04) and
fluorquinolone use was associated with number of veterinarians
employed in the practice (P = 0.02). Underdosing occurred in 15/
130 (12%) when the dose was compared to the licensed dose rates
and when compared to current scientific guidelines underdosing
was practiced by the majority (72%) of the respondents.
Inappropriate use of antimicrobials was common, and critically
important antimicrobials were chosen as fist line antimicrobials by
practitioners in Germany, Switzerland and Austria. Underdosing
is a common problem caused by the fact that the scientific guideli-
nes do not match with the mostly lower dosages approved by the
licensing authorities.
DEVELOPMENT AND VALIDATION OF AN EQUINE
CORONAVIRUS ELISA TO DETERMINE SEROLOGICAL
RESPONSES IN NATURALLY INFECTED HORSES. L.J.
Kooijman1, S.M. Mapes2, N. Pusterla2. 1Department of Equine
Sciences, Faculty of Veterinary Medicine, Utrecht University,
Utrecht, The Netherlands, 2Department of Medicine and Epidemi-
ology, School of Veterinary Medicine, University of California,
Davis, CA, USA
Equine coronavirus (ECoV) has recently been implicated in sev-
eral outbreaks of lethargy, anorexia and fever among adult horses.
The purpose of this study was to develop and validate an Enzyme-
Linked Immuno-Sorbent Assay (ELISA) targeting antibodies to
the spike (S) protein of ECoV. Acute and convalescent serum sam-
ples from 83 adult horses involved in 6 different outbreaks were
used. An ELISA starter accessory kit, the purified ECoV S-protein
and anti-horse IgG were used for this purpose. Optical density
(OD) values from the field samples, as well as from our positive
and negative control samples, were obtained using the ELISA.
The ELISA was able to reliably and repeatedly classify negative
and positive control serum samples. The average corrected thresh-
old OD was determined to be 0.955 with a standard deviation of
0.227. The assay was found to be linear over an OD range of
0.557–3.487. Intra-assay coefficient of variation ranged from 0.8 to
6.4%, with an average of 3.1%. The inter-assay coefficients of
variation ranged from 1.9 to 4.2%, with an average of 3.0%. The
greatest seroconversion rate was observed in horses with clinical
signs compatible with ECoV and ECoV qPCR detection in feces.
Results showed that the ECoV ELISA is able to reliably detect
antibodies to ECoV and could therefore be a valuable tool to
diagnose and monitor ECoV outbreaks in the future.
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